Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Long-Term Investments (2022)

Medicinova (MNOV) has disclosed Long-Term Investments for 3 consecutive years, with $10.0 million as the latest value for Q3 2022.

  • On a quarterly basis, Long-Term Investments changed N/A to $10.0 million in Q3 2022 year-over-year; TTM through Sep 2022 was $10.0 million, a N/A change, with the full-year FY2013 number at $680982.0, changed N/A from a year prior.
  • Long-Term Investments was $10.0 million for Q3 2022 at Medicinova, up from $690328.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $10.0 million in Q3 2022 to a low of $10.0 million in Q3 2022.